3861 results for «2520»
3861 results
Management of PCI complications - Part 2
17 May 2024 – From EuroPCR 2024
This session focuses on the management of various PCI complications, including iatrogenic dissection after diagnostic coronary angiography, sinus node artery occlusion, a stuck 6F guide in the axillary artery, and the retrieval of a broken balloon. The session features a series of case presentations and discussions,...
Personalised Vascular Care Award ceremony
16 May 2024 – From EuroPCR 2024
This session is the Personalised Vascular Care Award ceremony, sponsored by Abbott. The objectives and details of this session are not provided, as it is likely an event to recognize and celebrate achievements in the field of personalized vascular care.
Calcified lesions: one big challenge; several good options
17 May 2024 – From EuroPCR 2024
This session delves into the management of calcified coronary lesions, presenting various techniques and tools to address this common challenge. It covers topics such as the use of drug-coated balloons, rotational atherectomy, intravascular lithotripsy, and high-pressure non-compliant balloons. The session also includes a meta-analysis on the...
Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024
17 May 2024 – From EuroPCR 2024
Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.
References
- SOLVE-TAVI: Feistritzer HJ, et al....
TAVR in challenging anatomies
17 May 2024 – From EuroPCR 2024
This session focuses on navigating TAVR procedures in complex anatomical scenarios. It covers topics such as optimizing the position of a TAVR valve in a stentless bioprosthesis, managing an unexpected deep position of a TAVR implant, dealing with a completely radiolucent failing surgical bioprosthetic valve, and...
ACS: how to approach special clinical scenarios
17 May 2024 – From EuroPCR 2024
This session focuses on the management of acute coronary syndrome (ACS) in special clinical scenarios. It covers topics such as treating ACS with multivessel disease, managing an ACS and unstable patient, and addressing subacute myocardial infarction. The session features case presentations and discussions, providing insights and...
Thrombus management in a STEMI patient with high clot burden
17 May 2024 – From EuroPCR 2024
Discover the optimal timing for thrombus extraction and explore effective strategies for managing large thrombi. Learn about the latest tools and techniques, as well as the role of pharmacotherapy in supporting successful thrombus removal.
TAVI: how to prevent stroke
17 May 2024 – From EuroPCR 2024
This session focuses on strategies for preventing stroke during TAVI procedures. It features case presentations and discussions on the use of cerebral protection devices, including a novel full-body embolic protection device, and the management of complications such as cerebral hyperperfusion syndrome.
Transcatheter solutions for combined valve disease
17 May 2024 – From EuroPCR 2024
This session delves into the transcatheter management of patients with combined valve disease, including cases of concomitant aortic stenosis and mitral regurgitation, failed bioprostheses in both the aortic and mitral valves, and severe aortic regurgitation after previous valve-sparing root replacement. The session features case presentations and...
Non left main bifurcation - LIVE case
17 May 2024 – From EuroPCR 2024
A 53-year-old male presented with a late STEMI one month ago. Coronary angiography revealed three-vessel disease: CX occlusion (culprit lesion), RCA bifurcation stenosis, and severe mid LAD-D1 (1-1-1) stenosis. The operators performed RCA PCI during the STEMI hospitalization.
In this live case, they performed the LAD-D1 bifurcation...
Hot topics in interventional management of out-of-hospital cardiac arrest (OHCA)
17 May 2024 – From EuroPCR 2024
This session explores the latest insights and strategies for managing out-of-hospital cardiac arrest (OHCA) patients. Key topics include identifying OHCA patients who may benefit from immediate cathlab admission, the default PCI strategy in OHCA, and how to organize an effective OHCA network. Discussions will cover estimating...
PCI of bifurcation lesions: management of complications - Part 2
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 clinical case submissions showcasing the management of complications during PCI of bifurcation lesions. Cases cover topics such as navigating tricky ostial lesions, dealing with dissecting hematomas, undeflatable balloons, and distal left main perforations. Discussions focus on troubleshooting techniques and optimizing...
PCI of bifurcation lesions: management of complications - Part 3
17 May 2024 – From EuroPCR 2024
This session features additional selected EuroPCR 2024 clinical case submissions focusing on the management of complications during PCI of bifurcation lesions. Cases cover topics such as iatrogenic left main endarterectomy, left main dissections, and unexpected complications during various bifurcation stenting techniques. Discussions emphasize the importance of...
Advancements in intracoronary imaging and intervention: unmasking vulnerable plaques and optimising durable PCI outcomes
16 May 2024 – From EuroPCR 2024
Delve into this EuroPCR 2024 session to gain insights into NIRS IVUS, exploring its applications, supported by current data, and understanding its clinical significance. Learn how to utilize NIRS IVUS in PCI planning through case examples, addressing lesion characteristics such as length and calcific nodules. Explore local...
Supraflex Cruz - Improving patient outcomes: from simple to complex patients
14 May 2024 – From EuroPCR 2024
Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...
Mastering the future of PCI with drug-coated balloons
16 May 2024 – From EuroPCR 2024
Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...
QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlab
15 May 2024 – From EuroPCR 2024
Join this session to delve into the cutting-edge capabilities of the newest QFR technology, allowing for rapid coronary vessel analysis in under 30 seconds. Gain insight into the diagnostic potential of QFR-IMR for assessing coronary microvascular dysfunction and understand its implications for patient care. Explore the...
PCI in patients with diabetes: next generation DES + DCB stent platform in action
14 May 2024 – From EuroPCR 2024
Watch this session on PCI in diabetic patients to learn about a groundbreaking technology addressing the complexities of this critical subgroup. Discover the next-generation DES and DCB stent platform and the innovative Envisolution technology behind it. Understand how it works, its advantages in managing complex cases,...
Restoring vessel physiology drives outcomes - The Bioadaptor experience
16 May 2024 – From EuroPCR 2024
Join this session to delve into the unmet needs concerning drug-eluting stents (DES), including poor long-term clinical outcomes, with up to a 50% MACE rate at 10 years, and a non-plateauing 2-3% annual event rate. Explore how DynamX Bioadaptor technology addresses these challenges by maintaining the...
Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems
14 May 2024 – From EuroPCR 2024
Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...
